Community/Retail

The Rite Aid Foundation has announced a $125,000 donation to the American Red Cross to help the victims, families, and communities across the Southeastern United States that were affected by Hurricane Matthew.

Current guidelines for type 2 diabetes management recommend metformin as the first-line medication.

The FDA has granted Breakthrough Therapy Designation status to Roche's Actemra/RoActemra, also known as tocilizumab, for the treatment of giant cell arteritis.

Community pharmacy based pilot helps expand pharmacists' role in direct patient care services

Over the years, a number of landmark clinical studies on CHF have been published, shaping how we treat the disease today.

The PCAT and GRE have verbal testing components, which may not coincide with a student's science heavy preparation, so here are some tips on improving your word game fast.

Price Chopper and Market 32 have introduced a new mobile app in partnership with mscripts to help customers manage prescriptions on the go.

Adolescents underestimate their risk of contracting HIV, and 60% of infected patients are unaware of their status.

An attempted armed robbery turned deadly at a Medicap Pharmacy on Thursday, October 6, when a pharmacist was injured in a shooting.

It's time to focus on verifying the missing element to antibiotic prescriptions: the indication.

When an influenza pandemic breaks out, public health officials scurry to vaccinate as many individuals as they can.

Mylan has launched metformin hydrochloride extended-release tablets, the generic version of Watson's Fortamet, in 500 mg and 1000 mg doses.

We previously discussed various methods for attracting the best potential hires from the largest pool of qualified candidates.

Injuries from electronic cigarettes (e-cigarettes) are on the rise, which may pose a significant public health threat.

Before teenagers open the bathroom cabinet and pop open a medicine bottle that isn't theirs, is there a way to target at-risk teens and prevent addictive behavior?

Little information exists regarding the benefit of bridging warfarin among patients with atrial fibrillation. The best available evidence suggests that this common practice may increase the risk of bleeding without providing any efficacy benefit.

Globally, millions of children lack clean water, adequate food, and the basics of sustenance. Because of this, they often contract infections and develop health problems.

Eight individuals have been arrested for their involvement in an organized prescription fraud scheme in Texas.

The FDA has approved a new continuous glucose monitoring (CGM) system designed to provide health care professionals with clear, visual snapshots of glucose levels, trends, and patterns in patients with diabetes at a lower cost than other CGM devices on the market.

With the entrance of pharmacist requirements on some states' cannabis legislation, our health profession is obligated to keep an open mind toward the subject.

Almost all American consumers feel confident when choosing an OTC pain reliever to purchase, but few pay heed to key safety factors when doing so.

In case you missed it, here's the hottest news in pharmacy this week:

Bartell Drugs and Seattle's Union Gospel Mission have teamed to help protect the homeless and insecurely housed residents of the downtown core by distributing flu kits" and vouchers for free flu immunizations.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Certain interactions on Facebook may have a positive effect on users' psychological health.

The number of syphilis cases has risen steadily in the United States since 2000. Those who are at particularly elevated risk include men who have sex with men and patients infected with human immunodeficiency virus (HIV).

Nationally, the uninsured rate has reached a record low of 8.6%, according to CDC data. At the state and city levels, however, uninsured rates vary widely.

Lundbeck and Otsuka have received FDA approval to update the label of brexpiprazole (Rexulti) with clinical data supporting the drug's use as a maintenance treatment for schizophrenia in adults.